20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Antibiotic solution and method of injection to prevent ophthalmic infections
#7802Composition and methods for treating heritable pulmonary artery hypertension associated with nonsense mutations
#7803Method of treating liver fibrosis
#7804Autotaxin inhibitor compounds
#7805CABAZITAXEL COMPOSITION FOR INJECTION AND PREPARATION METHOD THEREFOR
#7806Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
#7807Stabilization of epinephrine formulations
#7808Sphingoid compounds for prophylaxis and/or therapy of a viral infection
#7809Trans-Catheter Local Immunotherapy for Solid Tumors
#7810STABLE VITAMIN B12 LIQUID FORMULATIONS
#7811NEBULIZING DEVICES AND SYSTEMS HAVING BIOMETRIC DATA ACQUISITION AND MONITORING CAPABILITIES
#7812Compositions and methods for treating leber's hereditary optic neuropathy
#7813Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)
#7814Therapeutic antibody formulation
#7815DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
#7816Melanin antibodies and uses thereof
#7817OXYNTOMODULIN PEPTIDE ANALOG FORMULATIONS
#7818Carbohydrate tethering at cell surfaces to induce immune response
#7819Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
#7820Extended release microparticles comprising drug, and preparation method therefor
#7821NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF
#7822Use of a Syncytin for Targeting Drug and Gene Delivery to Regenerate Muscle Tissue
#7823THERMOGEL FORMULATION FOR COMBINATION DRUG DELIVERY
#7824COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND USES THEREOF
#7825C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
#7826Factor IX polypeptide formulations
#7827METHODS OF TREATING AND PROTECTING AGAINST CARDIAC DISEASE, CARDIOVASCULAR DISEASE AND RELATED CONDITIONS AND SYMPTOMS
#7828CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
#7829Methods of prophylactic treatment using recombinant VWF (rVWF)
#7830Dry growth hormone composition transiently linked to a polymer carrier
#7831COMPOSITION FOR TREATMENT OF JOINT DISEASE AND METHOD THEREOF
#7832Anti-BCMA CAR T cell compositions
#7833HIGH CONCENTRATION FORMULATIONS
#7834COMPOSITIONS COMPRISING 3'-O-GLUCURONIDE EPICATECHIN AND METHODS OF MAKING AND USING SUCH COMPOSITIONS
#7835Fosfomycin formulation for parenteral administration
#7836Antitumor agent
#7837METHODS FOR EVALUATING TREATMENTS AND PHYSIOLOGY IN HUMAN PATIENTS USING INTRAVENOUS ALPHA-2 ADRENERGIC ANTAGONIST AGENTS
#7838TRPV4 antagonists
#7839METHODS FOR PAIN TREATMENT USING RESINIFERATOXIN
#7840USE AND METHOD OF L-ASPARTIC ACID beta-HYDROXAMATE IN PREPARING DRUGS FOR INHIBITING CHOROIDAL NEOVASCULARIZATION
#7841Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
#7842Injectable phenol formulations and methods of their use
#7843Treatment of schizophrenia using beta-caryophyllene and CB2 receptor agonists
#7844Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
#7845Lipid emulsion therapy for treating acute cannabinoid intoxication
#7846Composition for use in the treatment of mucous membrane lesions using endoscopic resection
#7847Hyaluronic acid composition
#7848DETECTION OF T-CELLS EXPRESSING BTNL8
#7849PH20 polypeptide variants, formulations and uses thereof
#7850Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation
#7851Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies
#7852Optimized anti-TL1A antibodies
#7853Method of treating an allergy with allergen-specific monoclonal antibodies
#7854VEGFR-FC FUSION PROTEIN FORMULATIONS
#7855High-purity large-scale preparation of stannsoporfin
#7856Inhibitors of menin-MLL interaction
#7857Drug composition for parenteral administration
#7858TWO-DRUG TYPE LOCAL INJECTION SOLUTION FOR SUBMUCOSAL INJECTION
#7859High concentration protein formulations with reduced viscosity
#7860Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)
#7861VACCINE COMPOSITION AND ADJUVANT
#7862EFFICACIOUS MRNA VACCINES
#7863Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#7864Stabilised Solid Compositions of Factor VII Polypeptides
#7865Pharmaceutical compositions and methods
#7866Injectable bone morphogenetic protein
#7867THERAPEUTIC AGENT OF UREMIA CONTAINING ALARIN AS THE MAIN INGREDIENT
#7868Daptomycin formulations
#7869Sincalide Formulations
#7870STABLE COMPOSITIONS OF NEUROACTIVE PEPTIDES
#7871TREATMENT OF TRIPLE NEGATIVE BREAST CANCER OR COLORECTAL CANCER WITH LIVER METASTASES WITH AN ANTI PD-L1 ANTIBODY AND AN ONCOLYTIC VIRUS
#7872AGENT FOR PROMOTING MIGRATION OF PLURIPOTENT STEM CELLS
#7873Compositions and methods for parenteral administration of therapeutic agents
#7874COMPOSITIONS COMPRISING ALPHA-POLYGLUTAMIC ACID-ZINC FOR TREATING CANCER
#7875Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
#7876Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof
#7877NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)
#7878Methods of identifying dosing regimens
#7879Methods of inhibiting pathological angiogenesis
#7880ADJUNCTIVE THERAPY WITH 25-HYDROXYVITAMIN D
#7881TRIPTONIDE OR A COMPOSITION COMPRISING TRIPTONIDE FOR USE IN TREATING DISORDERS
#7882Neuroactive steroids, compositions, and uses thereof
#7883THERAPEUTIC METHODS RELATING TO HSP90 INHIBITORS
#7884Methods for treating amyotrophic lateral sclerosis
#7885CRAC CHANNEL INHIBITOR COMPOSITIONS
#7886HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
#7887Ifetroban Treatment for Systemic Sclerosis
#7888Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
#7889METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING
#7890Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
#7891Conditioning irradiated tissue for increasing vascularity
#7892MATERIALS AND METHODS FOR THE CONTROL OF BIOFILM
#7893INTRANASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION
#7894Compounds for the prevention and treatment of glucose intolerance related conditions and obesity
#7895LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS IN HUMANS
#7896CELL AUTOPHAGY INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#7897VOLATILE ANESTHETIC COMPOSITIONS COMPRISING EXTRACTIVE SOLVENTS FOR REGIONAL ANESTHESIA AND/OR PAIN RELIEF
#7898Sterile Buffered Solution Injection to Burn Tissue
#7899Adeno-associated virus variant capsids and methods of use thereof
#7900METHODS OF TREATING GENETIC HEARING LOSS
#7901TLR9-TARGETED SPHERICAL NUCLEIC ACIDS HAVING POTENT ANTITUMOR ACTIVITY
#7902MiRNA Detargeting System for Tissue Specific Interference
#7903COMPOSITIONS AND METHODS FOR TREATMENT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)-RELATED DISORDERS
#7904Anti-IL2 receptor gamma antigen-binding proteins
#7905MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
#7906RECOMBINANT FOLLISTATIN-FC FUSION PROTEINS AND USE IN TREATING DUCHENNE MUSCULAR DYSTROPHY
#7907Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#79083-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors
#7909DRUG-IODINATED OIL DISPERSION, METHOD FOR PREPARING SAME AND ITS APPLICATION IN EMBOLIZATION TREATMENT FOR LIVER CANCER
#7910Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)
#7911Non-viral gene delivery agent comprising lipopeptide (LP) compounds
#7912Undecylenic acid-based nanocarriers for targeted drug delivery
#7913Anticancer drug-containing plant virus particles
#7914ASH1L inhibitors and methods of treatment therewith
#7915HYDROGEL-FORMING COMPOSITION FOR CONTROLLED RELEASE
#7916Pharmaceutical composition with improved storage stability and method for preparing the same
#7917PHARMACEUTICAL COMPOSITION
#7918METHOD FOR TREATING CANCER BASED ON METALLOFULLERENE MONOCRYSTALLINE NANOPARTICLES THAT SPECIFICALLY DISRUPT TUMOR BLOOD VESSELS
#7919ErbB peptide pharmaceutical and vaccine compositions and therapeutic uses thereof for cancer
#7920Gene therapy for treating Mucopolysaccharidosis type II
#7921Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression
#7922Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#7923Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#7924Methods and compositions for preventing and treating damage to the heart
#7925METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#7926Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#7927MULTIPOTENT ADULT PROJENITOR CELLS FOR TREATMENT OF ICH
#7928METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
#7929Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#7930Injectable monophase hydrogels
#7931Treatment of bone marrow pathologies with polysufated polysaccharides
#7932Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions
#7933Concentrated methotrexate solutions
#7934Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof
#7935Methods for solid tumor treatment
#7936INJECTABLE DIETHYLSTILBESTROL NANOSUSPENSION FORMULATION
#7937COMBINATION THERAPY COMPRISING NANOPARTICLES OF A TAXANE AND ALBUMIN WITH ABT-263 IN METHODS FOR TREATING CANCER
#7938Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy
#7939STABLE LIQUID COMPOSITIONS OF PEMETREXED
#7940Parenteral dosage form of diltiazem
#7941COMPOSITIONS AND METHODS FOR MONITORING PROGRESSION AND REGRESSION OF DISEASE IN PATIENTS IN RESPONSE TO THERAPY
#7942REG3A AND REG FAMILY MEMBER BIOMARKERS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CANCER
#7943Gene therapy for ceroid lipofuscinoses
#7944METHODS OF TREATING DIABETES AND/OR PROMOTING SURVIVAL OF PANCREATIC ISLETS AFTER TRANSPLANTATION
#7945Hydrogel for stem cell and organoid culture
#7946ANTI-IL-33 THERAPY FOR ATOPIC DERMATITIS
#7947Apelin peptides and uses thereof
#7948Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery
#7949Long-acting prodrugs of entecavir, preparing methods and uses thereof
#7950Dantrolene prodrugs and methods of their use
#7951Compounds as neurokinin-1 receptor antagonists and uses thereof
#7952Process for the preparation of a suspension of nanosized synthetic zeolite materials, suspensions of nanosized synthetic zeolite materials obtained by said process and their uses in therapy and diagnosis
#7953Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
#7954MOLECULES TARGETING SURVIVAL MOTOR NEURON 2
#7955STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF
#7956Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
#7957Methods and Compositions Useful for Treating Cancer
#7958STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A
#7959COMPOSITIONS AND METHODS FOR TREATING PSEUDOANEURYSM
#7960Rapid-acting insulin formulation comprising a substituted anionic compound
#7961Semaglutide in medical therapy
#7962COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#7963METHODS FOR MITIGATING LIVER INJURY AND PROMOTING LIVER HYPERTROPHY, REGENERATION AND CELL ENGRAFTMENT IN CONJUNCTION WITH RADIATION AND/OR RADIOMIMETIC TREATMENTS
#7964Methods of mitigating toxic effects of vesicants and caustic gas
#7965Combination of AS1411 and SAPC-DOPS for the treatment of glioblastoma multiforme
#7966Liquid Formalation of a VEGF Antagonist
#7967Hsp70 based combination therapy
#7968DAPTOMYCIN FORMULATIONS AND USES THEREOF
#7969METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#7970Methods of treating prostate cancer with GnRH antagonist
#7971METHODS FOR TREATING HYPOTENSION
#7972Recombinant rhabdovirus encoding for CCL21
#7973Sodium nitrite-containing pharmaceutical compositions
#7974Compositions and methods for treating an infection
#7975PALATINOSE FOR ENHANCING DIETARY SUPPLEMENT AND PHARMACEUTICAL DELIVERY
#7976Palatinose for enhancing dietary supplement and pharmaceutical delivery
#7977DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS BY SCREENING FOR L-FORM BACTERIA
#7978Preservative-free treprostinil devices
#7979Spirocyclic compounds as tryptophan hydroxylase inhibitors
#7980Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
#7981Dosage principle for drugs useful for treating neoplastic diseases
#7982BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#7983COX-2 Inhibitors for the Treatment of Ocular Disease
#7984Polymeric compositions of monomethyl fumarate and their use in treating relapsing remitting multiple sclerosis and psoriasis
#7985Viral Inhibitor
#7986Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility
#7987Method and composition for targeted delivery of therapeutic agents
#7988Long-acting non-aqueous injectable formulations and use thereof
#7989HEMOPEXIN FORMULATIONS
#7990Pharmaceutical Composition for Cancer Treatment
#7991Gene therapies for lysosomal disorders
#7992Gene therapies for lysosomal disorders
#7993INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF SERYL-TRNA SYNTHETASES
#7994METHODS OF TREATMENT WITH ANTI-FACTOR XI/XIA ANTIBODIES
#7995Subcutaneous formulations of anti-CD38 antibodies and their uses
#7996GPRC5D chimeric antigen receptors and cells expressing the same
#7997Ultra-long acting insulin-Fc fusion proteins and methods of use
#7998METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONS
#7999METHODS FOR TREATING HEADACHE
#8000PIC1 inhibition of myeloperoxidase oxidative activity in an animal model
#8001Systems, compositions and methods for treating diabetes
#8002COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS
#8003PROMININ-1 PEPTIDE FOR TREATING LUNG INJURY
#8004Gene therapy for treating familial hypercholesterolemia
#8005Method of treating stem cells with NAD
#8006Antiviral therapy
#8007N3-substituted iminopyrimidinones as antimalarial agents
#8008Enhanced immunotherapy of cancer using targeted transcriptional modulators
#8009TARGETED THERAPEUTICS
#8010Compounds for treating TNBC
#8011Pharmaceutical combinations
#8012Methods for treating diseases and nerve injuries
#8013Pamoate salt of monoamine anti-Parkinson's agents, method of preparation and use thereof
#8014Capric acid and myristic acid compositions for treating conditions
#8015Norepinephrine compositions and methods therefor
#8016Application for (2R, 4R)-1,2,4-trihydroxyheptadec-16-yne in preparation of pharmaceutical composition for preventing or treating hepatic injury
#8017NANOPARTICLES, METHODS AND USES THEREOF
#8018Pegylated liposomes for delivery of immunogen-encoding RNA
#8019Parenteral formulation comprising siponimod
#8020ENHANCED DRAINAGE OF FAILED GLAUCOMA DRAINAGE DEVICE (GDD)
#8021A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#8022De novo binding domain containing polypeptides and uses thereof
#8023Treating cancer by blocking the interaction of TIM-3 and its ligand
#8024TREATING REFRACTORY MIGRAINE
#8025Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#8026Pentaaza macrocyclic ring complexes possessing oral bioavailability
#8027Biodegradable, thermally responsive injectable hydrogel for treatment of ischemic cardiomyopathy
#8028Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof
#8029Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility
#8030Compositions and methods of modulating macrophage activity
#8031Pharmaceutical formulations and methods of use thereof
#8032Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
#8033Chitosan-pluronic complex and nano-carrier comprising same
#8034METHODS OF POPULATING PRECIPITATED PARTICLES OF A MODIFIED OR SYNTHESIZED SUBSTANCE IN A TISSUE
#8035Composition for treating and/or preventing Hepatitis B virus infection and the use thereof
#8036Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus
#8037Site-specific polyethylene glycolylated (pegylated) asparaginase, preparation method therefor and use thereof
#8038METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT
#8039GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST COMPOSITIONS
#8040Methods and compositions for modulating appetite and intake of sodium
#8041NEW THERAPY FOR OSTEOARTHRITIC PAIN
#8042METHODS AND COMPOSITIONS FOR CANCER TREATMENT
#8043Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
#8044USE OF PHENOTHIAZINE DERIVATIVE IN THE TREATMENT OF INFECTION CAUSED BY BACTERIA CARRYING TYPE IV PILI
#8045Combination therapy
#8046Combination therapies comprising targeted therapeutics
#8047Compound for treating osteoarthritis
#8048Cannabis and derivatives thereof for the treatment of pain and inflammation related with dental pulp and bone regeneration related to dental jaw bone defects
#8049BIMODAL MODIFIED RELEASE COMPOSITIONS FOR CANCER TREATMENT
#8050Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with n-acetylcysteine amide (NACA) or (2R,2R′)-3,3′-disulfanediyl BIS(2-acetamidopropanamide)(DiNACA)
#8051MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE
#8052Lipid nanoparticles and use thereof to deliver RNA polynucleotides
#8053ADRENALIN-CONTAINING DOUBLE LAYERED LIPID VESICLES FOR USE IN THE TREATMENT OF CARDIAC EMERGENCIES
#8054Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
#8055Succinylcholine prefilled syringe, compositions and methods
#8056Succinylcholine prefilled syringe, compositions and methods
#8057Succinylcholine prefilled syringe, compositions and methods
#8058GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT
#8059VECTORS AND METHODS OF USE
#8060IMMUNOPRIVILEGED BIOACTIVE RENAL CELLS FOR THE TREATMENT OF KIDNEY DISEASE
#8061Platform for generating safe cell therapeutics
#8062Compositions and methods to improve anti-angiogenic therapy and immunotherapy
#8063EGFR targeted therapy of neurological disorders and pain
#8064Compositions and methods for treating beta-globinopathies
#8065Acute treatment and rapid treatment of headache using anti-CGRP antibodies
#8066Substituted inhibitors of menin-MLL and methods of use
#8067Formulations with reduced degradation of polysorbate
#8068APOPTOSIS INHIBITOR FORMULATIONS FOR PREVENTION OF HEARING LOSS
#8069VACCINE ADJUVANT AND MICRONEEDLE PREPARATION
#8070Treatment of stress disorders, including post-traumatic stress disorder, using acetylcholine release inhibiting neurotoxic proteins to reduce stress levels
#8071Long-Acting Formulations of Insulin
#8072Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
#8073Use of CXCL12 for therapy after prostate surgery
#8074Compositions and methods for inhibiting intercellular interactions
#8075Use of jack bean lectin for increasing the abundance of hematopoietic stem cells and progenitor cells in bone marrow and/or epidermal stem cells in skin in vivo
#8076USE OF POLYPHENOL CONTAINING SUGAR CANE EXTRACTS FOR PREVENTING, IMPROVING OR TREATING A SKIN CONDITION
#8077Total flavonoid extract from Kitam., preparation method thereof, and use of same in treating non-alcoholic fatty liver disease
#8078Parvovirus formulation for treating tumors
#8079COMBINATION OF IMMUNO-ONCOLYTIC VIRUS DRUGS FOR ENHANCING SYSTEMIC IMMUNE RESPONSE AND APPLICATION THEREOF
#8080Compositions comprising bacterial strains
#8081EXOSOMES AND METHODS OF USE THEREOF
#8082Treating rotator cuff conditions
#8083Methods and compositions for treating skin
#8084Oligonucleotide analogues incorporating 5-aza-cytosine therein
#8085PALATINOSE FOR ENHANCING DIETARY SUPPLEMENT AND PHARMACEUTICAL DELIVERY
#8086Method to Abate Acute Airway Hypersensitivity and Asthma Attacks
#808717α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors
#8088Ophthalmic pharmaceutical composition, ophthalmic kit, and pharmaceutical application thereof
#8089TREATMENT OF TYPE I AND TYPE II DIABETES
#8090Method of treatment and dosage forms thereof
#8091Mast cell stabilizers for treatment of chronic inflammatory conditions
#8092Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene
#8093AUTOTAXIN INHIBITORS AND USES THEREOF
#8094Epinephrine compositions and containers
#8095Epinephrine compositions and containers
#8096PARENTERAL ADMINISTRATION OF TAPENTADOL
#8097Nanomaterials with enhanced drug delivery efficiency
#8098Expansile crosslinked polymersome for ph-sensitive delivery of anticancer drugs
#8099SELF-GELLING SOLUTIONS FOR ADMINISTRATION OF THERAPEUTICS TO THE INNER EAR
#8100INTRAVENOUS ADMINISTRATION OF TRAMADOL